Every cell in a blood vessel wall must decide whether to stay quiet and healthy or to grow and repair — and a single protein on their surface, neuropilin 1 (NRP1), appears to make that call. Researchers at the Wellcome Trust have discovered that NRP1 shuttles signals from outside the cell directly to the nucleus, telling endothelial cells whether to expand blood vessels in response to low oxygen or to remain stable and non-clotting. When this signalling goes wrong, cells become inflamed and prematurely aged — a state common in chronic diseases such as atherosclerosis, diabetes, and vascular dementia. This project will map exactly how NRP1 controls these decisions, revealing the molecular switches that toggle between healthy vessel maintenance and disease-prone dysfunction. The work is fundamental science: it asks how a single receptor integrates multiple environmental cues into a coherent cellular response. If successful, it could identify new drug targets for conditions where blood vessels fail — heart attacks, strokes, and poor wound healing — by restoring the cell’s ability to make the right decision at the right time.
View original technical description
At the interface between blood and tissues, vascular endothelial cells (ECs) provide signalling hubs for vascular adaptation to physiological needs. Quiescent ECs form a non-thrombotic surface that facilitates the exchange of gases, molecules and cells between blood and tissues, but they respond to hypoxia-induced signals with vascular expansion and regulate leukocyte extravasation in response to injury. Our unpublished observations indicate that the cell surface receptor neuropilin 1 (NRP1) relays signals from the extracellular environment to the endothelial nucleus to enable such context-dependent responses. Thus, we hypothesise that NRP1 integrates growth factor and extracellular matrix signalling with gene transcription programmes to balance EC behaviours that enable vascular growth and to prevent the senescent and proinflammatory endothelial phenotype common to many chronic diseases. To determine how vascular growth and homeostasis depend on NRP1-mediated pathways, we will investigate novel mechanisms by which NRP1 conveys signals for tissue vascularisation, protects ECs from premature senescence and regulates gene transcription for vascular growth and homeostasis. The knowledge gained will significantly advance our understanding of how extracellular signals are integrated with gene regulation to control EC behaviour, and will likely uncover pathways for therapeutic intervention in diseases with vascular dysfunction.
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.
Is something wrong? Let us know